Repligen (RGEN) Capital Expenditures Growth (3y) (2013 - 2026)
Repligen (RGEN) Capital Expenditures Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 129.26 Bn | 124.05 Bn | 1.96 Bn | -29.93% |
| 2 | Becton Dickinson | 46.23 Bn | 45.42 Bn | 2.15 Bn | -11.61% |
| 3 | Alcon | 33.66 Bn | 32.00 Bn | 1.53 Bn | -10.15% |
| 4 | Medline | 33.07 Bn | 30.84 Bn | 1.84 Bn | - |
| 5 | Resmed | 30.36 Bn | 28.70 Bn | 890.98 Mn | 5.31% |
| 6 | West Pharmaceutical Services | 24.00 Bn | 23.56 Bn | 329.20 Mn | -16.94% |
| 7 | Solventum | 14.89 Bn | 14.33 Bn | 1.10 Bn | 8.92% |
| 8 | Cooper Companies | 13.96 Bn | 13.82 Bn | 735.40 Mn | 5.49% |
| 9 | Baxter International | 12.52 Bn | 10.51 Bn | 891.00 Mn | -6.01% |
| 10 | Repligen | 8.44 Bn | 7.45 Bn | 108.28 Mn | -69.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.69% |
| Dec 31, 2025 | -19.96% |
| Sep 30, 2025 | -36.20% |
| Jun 30, 2025 | -7.10% |
| Mar 31, 2025 | -5.49% |
| Dec 31, 2024 | 12.52% |
| Sep 30, 2024 | -14.48% |
| Jun 30, 2024 | 79.87% |
| Mar 31, 2024 | -26.87% |
| Dec 31, 2023 | -58.27% |
| Sep 30, 2023 | -1.75% |
| Jun 30, 2023 | 85.05% |
| Mar 31, 2023 | 27.29% |
| Dec 31, 2022 | 28.86% |
| Sep 30, 2022 | -55.99% |
| Jun 30, 2022 | -10.78% |
| Mar 31, 2022 | -21.06% |
| Dec 31, 2021 | -80.65% |
| Sep 30, 2021 | 122.99% |
| Jun 30, 2021 | -57.32% |